Co-occurrence of affective and schizophrenia spectrum disorders with PINK1 mutations

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 78, Issue 5, 2007, Pages 532-535

  Steinlechner, Susanne ^a   Stahlberg, Jessica ^a   Völkel, Birgit ^a   Djarmati, Ana ^a   Hagenah, Johann ^a   Hiller, Anja ^a   Hedrich, Katja ^a   König, Inke ^a   Klein, Christine ^a   Lencer, Rebekka ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOTRANSFERASE; PTEN INDUCED PUTATIVE KINASE 1; UNCLASSIFIED DRUG; PROTEIN KINASE; PTEN INDUCED PUTATIVE KINASE; PTEN-INDUCED PUTATIVE KINASE;

ADULT; AGED; ARTICLE; BIPOLAR I DISORDER; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FAMILY HISTORY; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; MAJOR DEPRESSION; MONOGENIC DISORDER; MOOD DISORDER; OBSESSIVE COMPULSIVE DISORDER; PARKINSONISM; PERSONALITY DISORDER; PHENOTYPE; PRIORITY JOURNAL; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; STRUCTURED INTERVIEW; FEMALE; GENETICS; MALE; MIDDLE AGED; MUTATION; PEDIGREE; PSYCHOLOGICAL ASPECT;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; MUTATION; PARKINSONIAN DISORDERS; PEDIGREE; PROTEIN KINASES; SCHIZOPHRENIA;

EID: 34247231543     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2006.105676     Document Type: Article

References (17)

1. Oertel WH, Hoglinger GU, Caraceni T, et al. Depression in Parkinson's disease An update. Adv Neurol 2001;86:373-83.
2. Aarsland D, Larsen JP, Lim NG, et al. Range of neuropsychiatric disturbances in patients with Parkinson's disease, J Neurol Neurosurg Psychiatry 1999;67:492-6.
3. Fénelon G, Mahieux F, Huon R, et al. Hallucinations in Parkinson's disease. Brain 2000;123:733-45.
4. Khan NL, Graham E, Critchley P, et al. Parkin disease: a phenotypic study of a large case series. Brain 2003;126:1279-92.
5. Hatano Y, Li Y, Sato K, et al. Novel PINK1 mutations in early-onset parkinsonism. Ann Neurol 2004;56:424-7.
6. Valente EM, Salvi S, Ialongo T, et al. PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann Neurol 2004;56:336-41.
7. Rohé CF, Montagna P, Breedveld C, et al. Homozygous PINK1 C-terminus mutation causing early-onset Parkinsonism. Ann Neurol 2004;56:427-31.
8. Gandhi S, Muqit MMK, Stanyer L, et al. PINK1 protein in normal human brain and Parkinson's disease. Brain 2006;129:1720- 31.
9. Abou-Sleiman PM, Muqit MMK, McDonald NQ, et al. A heterozygous effect for PINK1 mutations in Parkinson's disease? Ann Neurol 2006;60:414-19.
10. Klein C, Schlossmacher MG. The genetics of Parkinson disease: implications for neurological care. Nat Clin Pract Neurol 2006;2:136-46.
11. Hedrich K, Hagenah J, Djarmati MS, et al. Clinical spectrum of homo- and heterozygous PINK1 mutations in a large German family. Arch Neurol 2006;63:833-8.
12. Wittehen HU, Wunderlich U, Gruschwitz S, et al. Strukturiertes klinisches interview für DSM-IV, 1 Auflage. Göttingen: Hogrefe-Verlag, 1997.
13. Endicott J, Andreasen N, Spitzer RL. Family history research diagnostic criteria. Biometrics research. New York: Psychiatric Institute, 1978.
14. Kendler KS, McGuire M, Gruenberg AM, et al. The Roscommon family study. I. Methods, diagnosis of probands, and risk of Schizophrenia in relatives. Arch Gen Psychiatry 1993;50:527-40.
15. Doheny DO, Brin MF, Morrison CE, et al. Phenotypic features of myoclonusdystonia in three kindreds. Neurology 2002;59:1187- 96.
16. Melamed E. Does treatment with dopamine agonists affect utilization of exogenous levodopa in the parkinsonian striatum? J Neural Transm 1995;45(Suppl):57-60.
17. Van Hove JL, Steyaert J, Matthijs G, et al. Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency. J Neurol Neurosurg Psychiatry 2006;77:18-23.